Idex CORP /DE/ 8-K filings

IDEX Corporation announced record second quarter sales of $921 million and record orders exceeding $1 billion, with adjusted diluted EPS up 12% to $2.32, leading to raised full-year guidance.

IDEX Corporation shareholders re-elected four directors and ratified executive compensation and auditor appointments.

IDEX Corporation announced robust first-quarter 2026 financial results, exceeding expectations with significant sales and earnings growth, leading to an upward revision of full-year guidance.

IDEX Corporation announced the elimination of the Senior Vice President, Chief Strategy and Innovation Officer position, held by Roopa Unnikrishnan, effective February 28, 2026.

IDEX Corporation announced record fourth quarter and full year 2025 financial results, driven by strong order growth in its Health & Science Technologies segment, particularly from AI-related projects.

IDEX Corporation announced the appointment of Sean M. Gillen as its new Chief Financial Officer and the departure of its Chief Human Resources Officer, Melissa S. Flores.

IDEX Corporation announced record third-quarter sales and orders, alongside a narrowed full-year EPS outlook, demonstrating solid execution in an uncertain macroeconomic environment.

IDEX Corporation's Board of Directors authorized an additional $635 million for share repurchases, bringing the total authorization to $1 billion, and declared a regular quarterly cash dividend of $0.71 per share.

IDEX Corporation announced second-quarter sales growth and adjusted EPS exceeding expectations, but revised its full-year earnings guidance downward due to a challenging macro-environment and delayed large orders.

IDEX Corporation's CFO, Abhishek Khandelwal, has resigned, and Akhil Mahendra has been appointed as interim CFO effective May 30, 2025.

IDEX Corporation held its Annual Meeting of Stockholders on May 8, 2025, and voted on the election of directors, executive compensation, ratification of the accounting firm, and a stockholder proposal.

IDEX Corporation announced its Q1 2025 results, featuring record orders but a decline in diluted EPS, alongside proactive cost containment measures.

IDEX Corporation has appointed Stephanie Disher and Matthijs Glastra to its Board of Directors, while David Parry and Livingston Satterthwaite will retire following the 2025 Annual Meeting of Stockholders.

IDEX Corporation announces record fourth-quarter sales of $863 million and provides its financial outlook for 2025, projecting organic sales growth of 1% to 3%.

IDEX Corporation's third-quarter results show a slight sales increase but a significant drop in reported earnings per share, alongside the completion of the Mott Corporation acquisition.

IDEX Corporation has completed its acquisition of Mott Corporation, enhancing its position in applied material science and expanding into high-value end markets.

IDEX Corporation has successfully completed a $500 million offering of 4.950% Senior Notes due 2029 to fund the acquisition of Mott Corporation.

IDEX Corporation has entered into an agreement to issue $500 million in senior notes to finance its acquisition of Mott Corporation.

IDEX Corporation announced its second quarter results with a 5% decrease in sales and a revised full-year outlook, projecting lower organic growth and earnings per share.

IDEX Corporation has agreed to acquire Mott Corporation for $1 billion in cash, enhancing its position in high-value end markets.

IDEX Corporation held its annual meeting on May 7, 2024, electing three Class II directors and approving several proposals, including executive compensation and the 2024 Incentive Award Plan.

IDEX Corporation's first quarter results showed a 5% decrease in sales, but exceeded expectations for adjusted earnings per share and demonstrated strong cash flow.

IDEX Corporation announced its Q4 and full year 2023 financial results, showing a mixed performance with sales down in Q4 but record sales for the full year, and provided a 2024 outlook with modest growth expectations.